If your company is interested, please have the AUTHORISED COMPANY REPRESENTATIVE proceed with registration below.
The Biotechnology Commercialisation Fund (BCF) has been relaunched with more favourable borrowing terms, including lower interest rates, deferred principal payments, and longer repayment periods.
The fund’s scope has also been expanded to support a broader range of commercialisation activities. Eligible uses of financing proceeds now include viable initial commercialisation initiatives, working capital for existing operations, and capital expansion requirements such as the purchase of used machinery or acquisition of business properties.
Send your questions by filling up the form below.
Corporate Office
Ground Floor, Menara Z10
Jalan Alamanda 2, Presint 1
62000 Wilayah Persekutuan
Putrajaya, Malaysia.
